NVCT
Nuvectis Pharma, Inc.Company with tickers: NVCT
CIK
1875558
CUSIP
67080T108
Shares Outstanding
26,525,533
13F Activity (30d)
53 filings
51 filers
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | — | ||||
| Research & Development | $3,680,000 | USD | 2025-03-31 | 10-Q | 2026-05-05 |
| Operating Income | $-5,568,000 | USD | 2025-03-31 | 10-Q | 2026-05-05 |
| Net Income | $-5,332,000 | USD | 2025-03-31 | 10-Q | 2026-05-05 |
| EPS (Basic) | $-0.27 | USD/shares | 2025-03-31 | 10-Q | 2026-05-05 |
| EPS (Diluted) | $-0.27 | USD/shares | 2025-03-31 | 10-Q | 2026-05-05 |